Panel Discussion: What Should be the Future of Studies for Mitral and Tricuspid Valves?

Monday, February 27, 2023

2:40 PM – 3:15 PM ET

Panel Moderator(s)

Steven F. Bolling, MD

Professor of Cardiac Surgery
University of Michigan Hospital
Ann Arbor, Michigan, United States

Disclosure(s): xDot: Officer or Board Member (Ongoing)
Jaime Raben, PhD

Engineer
FDA
Silver Spring, Maryland, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Howard C. Herrmann, MD, FACC, MSCAI

Director, Interventional Cardiology and Cardiac Cath Labs
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)
Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No relevant disclosure to display
Saibal Kar, MD, FSCAI, FACC

DIrector of Structural heart disease interventions and Research Physician Director, Interventional Cardiology, HCA Healthcare
Los Robles Regional Medical Center, Thousand Oaks, CA
Los Angeles, California, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific, V wave, LAMINAR: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing)
Francesco Maisano, MD

University
zurich, Zurich, Switzerland

Disclosure information not submitted.
Ian T. Meredith, MD, PhD, FACC (he/him/his)

Executive Vice President and Global Chief Medical Officer
Boston Scientific Corporation
Marlborough, Massachusetts, United States

Disclosure(s): Boston Scientific Corporation: Employee (Ongoing), Major Stockholder (not including mutual funds) (Ongoing)
Neil E. Moat, MS, FRCS (he/him/his)

Chief Medical Officer/DVP, Structural Heart
Abbott
Santa Clara, California, United States

Disclosure information not submitted.
Thomas Modine, MD, PhD, MBA

Chief of structural and innovation
CHU de Bordeaux
Bordeaux , Aquitaine, France

Disclosure(s): Abbott: Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Consulting fees or other remuneration (Ongoing), Grant Recipient (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Educational Grant (Ongoing); Medtronic: Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Consulting fees or other remuneration (Ongoing), Grant/Research Support (Ongoing)
MM

Mauro Moscucci, MD, MBA, MPH

Medical Officer
Food and Drug Administration, Center for Devices and Radiological Health, Maryland, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Steven F. Bolling, MD: xDot: Officer or Board Member (Ongoing)

Jaime Raben, PhD: No financial relationships to disclose

Howard C. Herrmann, MD, FACC, MSCAI: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Highlife Medical: Contracted Research (Ongoing); Holistick Medical: Stock Shareholder (excluding mutual funds) (Ongoing); Innovalve: Grant/Research Support (Ongoing); medtronic: Consultant (Ongoing); Microinterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Wells Fargo: Consulting Fees (e.g., advisory boards) (Ongoing); WL Gore & Associates: Consulting fees or other remuneration (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing)

Samir R. Kapadia, MD, FSCAI: No relevant disclosure to display

Saibal Kar, MD, FSCAI, FACC: Abbott Vascular, Medtronic, Boston Scientific, V wave, LAMINAR: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing)

Ian T. Meredith, MD, PhD, FACC: Boston Scientific Corporation: Employee (Ongoing), Major Stockholder (not including mutual funds) (Ongoing)

Thomas Modine, MD, PhD, MBA: Abbott: Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Consulting fees or other remuneration (Ongoing), Grant Recipient (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Educational Grant (Ongoing); Medtronic: Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Consulting fees or other remuneration (Ongoing), Grant/Research Support (Ongoing)

Mauro Moscucci, MD, MBA, MPH: No financial relationships to disclose